**Question:** All the following statements about alpha-glucosidase inhibitors are true except:

A. Alpha-glucosidase inhibitors are used to treat diabetes mellitus type 2.
B. They work by inhibiting the enzymes that break down carbohydrates in the small intestine.
C. They decrease the absorption of glucose from the gut into the bloodstream.
D. They are contraindicated in patients with diabetes mellitus type 1.

**Correct Answer:** D. Alpha-glucosidase inhibitors are contraindicated in patients with diabetes mellitus type 1.

**Core Concept:**
Alpha-glucosidase inhibitors are a class of drugs used in the management of diabetes mellitus type 2. They work by inhibiting the enzymes responsible for breaking down carbohydrates in the small intestine, thereby reducing the absorption of glucose from the gut into the bloodstream.

**Why the Correct Answer is Right:**
Diabetes mellitus type 1 is a condition characterized by absolute insulin deficiency due to autoimmune destruction of pancreatic beta cells. Since alpha-glucosidase inhibitors work by reducing glucose absorption, they would not be effective in these patients. Additionally, since they require exogenous insulin for survival, administering alpha-glucosidase inhibitors could lead to dangerous hypoglycemia.

**Why Each Wrong Option is Incorrect:**
A. While alpha-glucosidase inhibitors are indeed used to treat diabetes mellitus type 2, the question specifically mentions that all statements are true, except for option D.

B. This option is incorrect because, although alpha-glucosidase inhibitors work by inhibiting the enzymes responsible for carbohydrate digestion, it does not mention the contraindication for type 1 diabetes patients.

C. This option is correct, explaining the mechanism of action of alpha-glucosidase inhibitors, which is crucial for understanding their therapeutic effect in managing blood glucose levels.

D. This option is correct due to the contraindication for alpha-glucosidase inhibitors in patients with diabetes mellitus type 1. Administering these drugs to these patients could lead to life-threatening hypoglycemia.

**Clinical Pearl:**
In treating patients with diabetes mellitus, it is crucial to consider the specific type of diabetes. While alpha-glucosidase inhibitors are useful in managing type 2 diabetes, they should not be used in patients with type 1 diabetes due to the risk of severe hypoglycemia. Always ensure a comprehensive understanding of the patient's diagnosis and disease type before prescribing any medication, including alpha-glucosidase inhibitors.